PYXS
Pyxis Oncology Inc
2.20$
+4.7%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 74.5% | 71.7% | 78.3% | 77.3% | 76.2% | 84.3% | 82.3% | 81.1% | 78.7% | 78.8% | 70.9% | 66.9% | |
| 7.9% | 5.6% | 12.7% | 12.0% | 6.2% | 12.4% | 9.4% | 8.7% | 8.4% | 16.9% | 11.3% | 34.3% | |
| 71.2% | 68.7% | 71.3% | 74.7% | 74.1% | 80.8% | 77.6% | 72.2% | 72.2% | 73.1% | 66.1% | 60.1% | |
| – | 0.0% | 3.6% | – | – | – | – | 2.4% | – | 0.8% | – | – | |
| – | – | 0.0% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | 1.9% | – | – | – | – | – | |
| 11.9% | 14.0% | 10.8% | 11.4% | 12.1% | 1.7% | 1.9% | 2.0% | 2.3% | – | – | – | |
| 26.1% | 27.6% | 16.4% | 18.5% | 21.3% | 23.2% | 24.1% | 28.9% | 34.9% | 41.6% | 51.4% | 79.2% | |
| 15.2% | 14.8% | 6.4% | 8.1% | 10.4% | 11.2% | 10.6% | 14.3% | 18.4% | 23.1% | 25.7% | 50.0% | |
| 0.6% | 0.7% | 0.5% | 0.6% | 0.7% | 0.9% | 1.1% | 1.3% | 1.5% | 1.8% | 2.7% | 3.3% | |
| 1.8% | 2.2% | 1.0% | 2.6% | 2.5% | 3.1% | 2.1% | 7.6% | 9.2% | 11.9% | 7.8% | 6.0% | |
| 73.9% | 72.4% | 83.6% | 81.5% | 78.7% | 76.8% | 75.9% | 71.1% | 65.1% | 58.4% | 48.6% | 20.8% | |
| -145.0% | -164.8% | -131.5% | -147.2% | -167.9% | -231.3% | -283.2% | -327.1% | -402.5% | -484.2% | -725.4% | -895.4% | |
| 22.1% | 25.8% | 23.3% | 29.0% | 31.1% | 38.6% | 44.9% | 50.3% | 59.2% | 67.9% | 98.7% | 116.5% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.